Skip to Content

CM 215 (Invokamet 150 mg / 500 mg)

Generic Name: canagliflozin/metformin

Pill with imprint CM 215 is Yellow, Capsule-shape and has been identified as Invokamet 150 mg / 500 mg. It is supplied by Janssen Pharmaceuticals, Inc..

Invokamet is used in the treatment of cardiovascular risk reduction; diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Invokamet 150 mg / 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for CM 215

Invokamet 150 mg / 500 mg CM 215

Invokamet

Generic Name
canagliflozin/metformin
Imprint
CM 215
Strength
150 mg / 500 mg
Color
Yellow
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antidiabetic combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Janssen Pharmaceuticals, Inc.
National Drug Code (NDC)
50458-0542

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.